GGrantIndex
← Leaderboards

William R. Drobyski

Medical College Of Wisconsin

$18,734,918
Attributed
$21,214,906
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,214,906 · 9

By mechanism

R01$21,109,906 · 8
R29$105,000 · 1

Top collaborators

Most similar at Medical College Of Wisconsin

Same institution · by research overlap

Others in their field

Top investigators on “Design

Research focus

DesignComplicationPlayFunctional DisorderBone Marrow TransplantationPathway InteractionsT-LymphocyteMediatingInflammatoryCellsAllogenicTransplant RecipientsAffectOrganInsightInflammationTissuesSiteClinically RelevantLeadStem Cell TransplantAcuteSeverity Of IllnessProduction

Grant awards (49)

Inflammatory Cytokine Networks in Gastrointestinal Tract Graft Versus Host Disease$608,125
R01 · FY2025 · HL · contact PI
Inflammatory Cytokine Networks in Gastrointestinal Tract Graft Versus Host Disease$608,125
R01 · FY2024 · HL · contact PI
Blockade of IL-23 for the Prevention of Graft Versus Host Disease$555,103
R01 · FY2024 · HL · contact PI
Mechanistic Inflammatory Pathways in Graft Versus Host Disease$700,162
R01 · FY2023 · HL · contact PI
Blockade of IL-23 for the Prevention of Graft Versus Host Disease$566,431
R01 · FY2023 · HL · contact PI
Mechanistic Inflammatory Pathways in Graft Versus Host Disease$700,162
R01 · FY2022 · HL · contact PI
Blockade of IL-23 for the Prevention of Graft Versus Host Disease$558,195
R01 · FY2022 · HL · contact PI
Inflammatory Cytokine Networks in Gastrointestinal Tract Graft Versus Host Disease$504,154
R01 · FY2022 · HL · contact PI
Mechanistic Inflammatory Pathways in Graft Versus Host Disease$700,162
R01 · FY2021 · HL · contact PI
Blockade of IL-23 for the Prevention of Graft Versus Host Disease$558,195
R01 · FY2021 · HL · contact PI
Inflammatory Cytokine Networks in Gastrointestinal Tract Graft Versus Host Disease$504,154
R01 · FY2021 · HL · contact PI
Mechanistic Inflammatory Pathways in Graft Versus Host Disease$695,482
R01 · FY2020 · HL · contact PI
Cannabinoid-mediated mitigation of graft versus host disease: Roles of CB2 receptors and adenosine signaling$543,312
R01 · FY2020 · HL · contact PI
Inflammatory Cytokine Networks in Gastrointestinal Tract Graft Versus Host Disease$504,154
R01 · FY2020 · HL · contact PI
Cannabinoid-mediated mitigation of graft versus host disease: Roles of CB2 receptors and adenosine signaling$543,312
R01 · FY2019 · HL · contact PI
Inflammatory Cytokine Networks in Gastrointestinal Tract Graft Versus Host Disease$507,117
R01 · FY2019 · HL · contact PI
Cannabinoid-mediated mitigation of graft versus host disease: Roles of CB2 receptors and adenosine signaling$538,692
R01 · FY2018 · HL · contact PI
Role of Interleukin 23 in Gastrointestinal GVHD$385,000
R01 · FY2018 · HL · contact PI
Cannabinoid-mediated mitigation of graft versus host disease: Roles of CB2 receptors and adenosine signaling$538,692
R01 · FY2017 · HL · contact PI
Role of Interleukin 23 in Gastrointestinal GVHD$385,000
R01 · FY2017 · HL · contact PI
Role of Interleukin 23 in Gastrointestinal GVHD$385,000
R01 · FY2016 · HL · contact PI
Regulatory T Cell Populations in Graft versus Host Disease$382,500
R01 · FY2016 · HL · contact PI
Role of Interleukin 23 in Gastrointestinal GVHD$382,916
R01 · FY2015 · HL · contact PI
Regulatory T Cell Populations in Graft versus Host Disease$376,762
R01 · FY2015 · HL · contact PI
Regulatory T Cell Populations in Graft versus Host Disease$374,850
R01 · FY2014 · HL · contact PI
Regulatory T Cell Populations in Graft versus Host Disease$364,140
R01 · FY2013 · HL · contact PI
Role of Interleukin 23 in the Pathophysiology of GVH and GVL Reactivity$301,317
R01 · FY2013 · DK · contact PI
Role of Interleukin 23 in the Pathophysiology of GVH and GVL Reactivity$312,246
R01 · FY2012 · DK · contact PI
Graft Versus Host Disease and Autoimmunity$378,750
R01 · FY2011 · HL · contact PI
Role of Interleukin 23 in the Pathophysiology of GVH and GVL Reactivity$312,246
R01 · FY2011 · DK · contact PI
Role of Interleukin 23 in the Pathophysiology of GVH and GVL Reactivity$380,000
R01 · FY2010 · DK · contact PI
Augmentation of GVL Reactivity Without GVHD$378,750
R01 · FY2010 · HL · contact PI
Graft Versus Host Disease and Autoimmunity$378,750
R01 · FY2010 · HL · contact PI
Augmentation of GVL Reactivity Without GVHD$378,750
R01 · FY2009 · HL · contact PI
Graft Versus Host Disease and Autoimmunity$378,750
R01 · FY2009 · HL · contact PI
Augmentation of GVL Reactivity Without GVHD$378,750
R01 · FY2008 · HL · contact PI
Graft Versus Host Disease and Autoimmunity$378,750
R01 · FY2008 · HL · contact PI
Graft Versus Host Disease and Autoimmunity$378,750
R01 · FY2007 · HL · contact PI
Augmentation of GVL Reactivity Without GVHD$378,750
R01 · FY2007 · HL · contact PI
Regulation of Engraftment &Immunity by GD T Cells$337,500
R01 · FY2005 · HL
Regulation of Engraftment &Immunity by GD T Cells$337,500
R01 · FY2004 · HL
MODULATING GVH/GVL POST-BMT USING TK EXPRESSING T CELLS$312,615
R01 · FY2004 · HL
Regulation of Engraftment &Immunity by GD T Cells$337,500
R01 · FY2003 · HL
MODULATING GVH/GVL POST-BMT USING TK EXPRESSING T CELLS$312,615
R01 · FY2003 · HL
Regulation of Engraftment &Immunity by GD T Cells$337,500
R01 · FY2002 · HL
MODULATING GVH/GVL POST-BMT USING TK EXPRESSING T CELLS$312,615
R01 · FY2002 · HL
MODULATING GVH/GVL POST-BMT USING TK EXPRESSING T CELLS$312,615
R01 · FY2001 · HL
MODULATING GVH/GVL POST-BMT USING TK EXPRESSING T CELLS$324,990
R01 · FY2000 · HL
GAMMA DELTA T CELLS AND ALLOENGRAFTMENT AND GVHD$105,000
R29 · FY2000 · HL